Author:
El-Karaksy Hanaa,Fahmy Mona,El-Raziky Mona,El-Koofy Nehal,El-Sayed Rokaya,Rashed Mohamed S.,El-Kiki Hasan,El-Hennawy Ahmad,Mohsen Nabil
Publisher
Springer Science and Business Media LLC
Subject
Pediatrics, Perinatology and Child Health
Reference33 articles.
1. Labelle Y, Phaneuf D, Leclerc B, Tanguay RM. Characterization of the human fumarylacetoacetate hydrolase gene and identification of a missense mutation abolishing enzymatic activity. Hum Mol Genet 1993;2:941–946.
2. Lindblad B, Lindstedt S, Steen G. On the enzymic defects in hereditary tyrosinemia. Proc Natl Acad Sci USA 1977;74:4641–4645.
3. Kvittingen E. Hereditary tyrosinemia type I-an overview. Scand J Clin Lab Invest Suppl 1986;184:27–34.
4. Russo P, O’Regan S. Visceral pathology of hereditary tyrosinemia type I. Am J Hum Genet 1990;47:317–324.
5. Lindstedt S, Holme E, Lock EA, Hjalmarson O, Strandvik B. Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase. Lancet 1992;340:813–817.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献